GuariguataL,WhitingD,HambletonI,BeagleyJ,LinnenkampU,ShawJ, 2014.Global estimates of diabetes prevalence for 2013 and projections for 2035,Diabetes Res Clin Pract 103 137 -49
TangSC,ChanGC,LaiKN, 2016.Recent advances in managing and understanding diabetic nephropathy,F1000Res 31 5 -
MacIsaacRJ,TsalamandrisC,PanagiotopoulosS,SmithTJ,McNeilKJ,JerumsG, 2004.Nonalbuminuric renal insufficiency in type 2 diabetes,Diabetes Care 27 195 -200
2015.,Index. Diabetes Care 38 S90 -3
PerroneRD,MadiasNE,LeveyAS, 1992.Serum creatinine as an index of renal function: new insights into old concepts,Clin Chem 38 1933 -53
LacquanitiA,DonatoV,PintaudiB,Di ViesteG,ChiricoV,BuemiA, 2013.Normoalbuminuric diabetic nephropathy: tubular damage and NGAL,Acta Diabetol 50 935 -42
AvinashS,SinghV,AgarwalA,ChatterjeeS,AryaV, 2015.Identification and stratification of diabetic kidney disease using serum cystatin C and serum creatinine based estimating equations in type 2 diabetes: A comparative analysis,J Assoc Physicians India 63 28 -
JavanmardiM,AzadiN-A,AminiS,AbdiM., 2015.Diagnostic value of cystatin C for diagnosis of early renal damages in type 2 diabetic mellitus patients: The first experience in Iran,J Res Med Sci 20 571 -
RossingP,HougaardP,ParvingHH, 2005.Progression of microalbuminuria in type 1 diabetes: ten-year prospective observational study,Kidney Int 68 1446 -50
MacIsaacRJ,EkinciEI,JerumsG, 2014.Markers of and risk factors for the development and progression of diabetic kidney disease,Am J Kidney Dis 63 S39 -62
KumarAA, 2015.Comparison of various formulas used to calculate eGFR in type 2 diabetes mellitus,Int J Health Sci Res 5 283 -9
MussapM,Dalla VestraM,FiorettoP,SallerA,VaragnoloM,NosadiniR, 2002.Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients,Kidney Int 61 1453 -61
ShemeshO,GolbetzH,KRIssJP,MyersBD, 1985.Limitations of creatinine as a filtration marker in glomerulopathic patients,Kidney Int 28 830 -8
CaramoriML,FiorettoP,MauerM, 2003.Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients an indicator of more advanced glomerular lesions,Diabetes 52 1036 -40
ChristenssonA,GrubbA,NilssonJ,NorrgrenK,SternerG,SundkvistG, 2004.Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy,J Intern Med 256 510 -8
GabrielIC,NishidaSK,KirsztajnGM, 2011.Serum cystatin C: a practical alternative for renal function evaluation?,J Brasileiro Nefrol 33 261 -7
FathimahM,AlicezahMK,ThevarajahM. Neutrophil, 2012.Gelatinase-Associated Lipocalin (NGAL): an early marker for diabetic nephropathy,Int J Diabetes Dev Ctries 32 19 -24
de CarvalhoJAM,TatschE,HausenBS,BollickYS,MorettoMB,DuarteT, 2016.Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes,Clin Biochem 49 232 -6
El-KafrawyNA,ShohaibAA,El-DeenSMK,El BarbaryH,SeleemAS, 2014.Evaluation of serum cystatin C as an indicator of early renal function decline in type 2 diabetes,Menoufia Med J 27 60 -
SinglaK,SodhiK,PandeyR,SinghJ,SharmaP., 2014.The utility of serum cystatin C in the diagnosis of early diabetic nephropathy,J Pharm Biomed Sci 4 84 -7
RaoGSN,AbayambigaiJ,SrutiE,SowmiyaK., 2014.Early prediction of nephropathy and cardiovascular diseases in Indian patients with type 2 diabetes mellitus,Int J Med Sci Public Health 3 1523 -7
SuzukiY,MatsushitaK,SeimiyaM,YoshidaT,SawabeY,OgawaM, 2012.Serum cystatin C as a marker for early detection of chronic kidney disease and grade 2 nephropathy in Japanese patients with type 2 diabetes,Clin Chem Lab Med 50 1833 -9